biowaiver for Sim­va­statin sus­pension [Dissolution / BCS / IVIVC]

posted by Dr_Dan  – Germany, 2015-05-18 11:58 (3703 d 10:59 ago) – Posting: # 14847
Views: 7,132

Dear PJS
Applying for a BCS-based biowaiver is restricted to highly soluble drug substances with known human absorption (BCS class I&III). As you already stated above simvastatin is no highly soluble drug (BCS class II with a high intra-subject variability). Only if an active substance is considered highly soluble, it is reasonable to expect that it will not cause any bioavailability problems. In case of simvastatin you will not be able to determine the formulation effect unless you have performed a BE study.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,686 registered users;
93 visitors (0 registered, 93 guests [including 16 identified bots]).
Forum time: 22:58 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5